Zabrina Brumme, University of British Columbia

Research

Antiretroviral Treatment Clinical Outcomes Epidemiology Hiv Reservoir Treatment Guidelines Viral Load

Latest papers

CTN 328: immunogenicity outcomes in people living with HIV in Canada following vaccination for COVID-19 (HIV-COV): protocol for an observational cohort study.
BMJ open · 2021
Impact of HLA-driven HIV adaptation on virulence in populations of high HIV seroprevalence.
Proceedings of the National Academy of Sciences of the United States of America · 2014
Rare mutations at codon 103 of HIV-1 reverse transcriptase can confer resistance to non-nucleoside reverse transcriptase inhibitors.
AIDS (London, England) · 2005

All 3 publications

Latest funding

Persistent Low-Level HIV Viremia During Antiretroviral Therapy: Origins and Clinical Consequences
CIHR · 2024 · Principal investigator
$1,147,500
Hepatitis C virus transmission dynamics among injection drug users
CIHR · 2011 · Co-investigator
$336,569

All 2 grants and awards

3 publications.

01

CTN 328: immunogenicity outcomes in people living with HIV in Canada following vaccination for COVID-19 (HIV-COV): protocol for an observational cohort study.

Costiniuk CT, Singer J, Langlois MA, Kulic I, Needham J, Burchell A, Jenabian MA, Walmsley S, Ostrowski M, Kovacs C, Tan D, Harris M, Hull M, Brumme Z, Brockman M, Margolese S, Mandarino E, Angel JB, Routy JP, Anis AH, Cooper C

BMJ open2021

DOI: 10.1136/bmjopen-2021-054208 PMID: 34916326

02

Impact of HLA-driven HIV adaptation on virulence in populations of high HIV seroprevalence.

Payne R, Muenchhoff M, Mann J, Roberts HE, Matthews P, Adland E, Hempenstall A, Huang KH, Brockman M, Brumme Z, Sinclair M, Miura T, Frater J, Essex M, Shapiro R, Walker BD, Ndung'u T, McLean AR, Carlson JM, Goulder PJ

Proceedings of the National Academy of Sciences of the United States of America2014

DOI: 10.1073/pnas.1413339111 PMID: 25453107

03

Rare mutations at codon 103 of HIV-1 reverse transcriptase can confer resistance to non-nucleoside reverse transcriptase inhibitors.

Harrigan PR, Mo T, Wynhoven B, Hirsch J, Brumme Z, McKenna P, Pattery T, Vingerhoets J, Bacheler LT

AIDS (London, England)2005

DOI: 10.1097/01.aids.0000163930.68907.37 PMID: 15802972

Persistent Low-Level HIV Viremia During Antiretroviral Therapy: Origins and Clinical Consequences

Principal investigatorCIHR2024Project Grant

Principal investigators: Lima, Viviane D; Brumme, Zabrina

Keywords: Antiretroviral Treatment; Clinical Outcomes; Epidemiology; Hiv; Reservoir; Treatment Guidelines; Viral Load

$1,147,500

Hepatitis C virus transmission dynamics among injection drug users

Co-investigatorCIHR2011Operating Grant - PA: Hepatitis C - Psycho-social/behavioural/epidemiological

Principal investigators: Krajden, Mel; Grebely, Jason

Keywords: Cohort Study; Epidemiology; Hepatitis C Virus; Injection Drug Users; Natural History; Phylodynamics; Phylogenetics; Public Health; Transmission

$336,569

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Frequent collaborators

Medicine
Infectious Diseases
Psychology
Department of Medicine
Sexologie
Microbiology and Immunology
Sciences biologiques
Other

1 shared papers, latest 2021

Mario Ostrowski

Medicine

1 shared papers, latest 2021

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mentionMention their CIHR grant from 2024

Subject: Prospective PhD student: Antiretroviral Treatment Dear Professor Brumme, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "CTN 328: immunogenicity outcomes in people living with HIV in Canada following vaccination for COVID-19 (HIV-COV): protocol for an observational cohort study." (2021), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Persistent Low-Level HIV Viremia During Antiretroviral Therapy: Origins and Clinical Consequences" (2024), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]